PBYI Puma Biotechnology
- 4.830
- -0.300-5.85%
Puma Biotechnology News
Puma Biotechnology | SC 13G: Statement of acquisition of beneficial ownership by individuals-James N. Topper(5.4%),Patrick J. Heron(5.4%), etc.
Puma Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer AUERBACH ALAN H
Puma Biotechnology | 8-K: Current report
Puma Biotechnology | 10-K: Annual report
Puma Biotechnology | 8-K: Puma Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results
Puma Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer Wong Alvin F
Puma Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer NOUGUES MAXIMO F
Puma Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer Ludwig Jeffrey Jerome
Puma Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer AUERBACH ALAN H
Puma Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer HUNT DOUGLAS M
Puma Biotechnology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Camber Capital Management LP(Camber Capital Management LP – 5.90%),Stephen DuBois Not applicable(Stephen DuBois – 5.90%)
Puma Biotechnology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(7.99%)
Puma Biotechnology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Anders Hove(6.2%),Acorn Bioventures 2 L.P.(3.6%), etc.
Puma Biotechnology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Millennium Management LLC(6.7%),Millennium Group Management LLC(6.7%), etc.
Puma Biotechnology | 8-K: Current report
Puma Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer Wong Alvin F
Puma Biotechnology | 144/A: Others
Puma Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer Wong Alvin F
Puma Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer AUERBACH ALAN H
Puma Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer Ludwig Jeffrey Jerome
Analysis
Price Target
No Data
